Clinical Trial Update: Flaxseed Lignan Supplementation in Elderly Participants With Stage I Hypertension [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating flaxseed lignan supplementation in elderly individuals with Stage I hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• flaxseed lignan supplement

Snippet

Sponsor: University of Saskatchewan | Conditions: Hypertension | Phase 2 | Status: COMPLETED